Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2001
08/21/2001US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91)
08/21/2001US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
08/21/2001US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans.
08/21/2001CA2121889C Production and use of multimeric hemoglobins
08/21/2001CA2097916C Subunit papillomavirus vaccine and peptides for use therein
08/21/2001CA2059167C Expression of human serum albumin in pichia pastoris
08/16/2001WO2001059458A1 Specific monoclonal antibody against terbinafine
08/16/2001WO2001059147A1 PROTEIN AND OAT β GLUCAN HYDROLYSATE FOR USE IN COSMETOLOGY AND METHOD FOR MAKING SAME
08/16/2001WO2001059145A1 Regulated expression of plac in staphylococcus aureus
08/16/2001WO2001059133A1 Larynx carcinoma-associated protein larcap-1
08/16/2001WO2001059120A2 Il-17 like molecules and uses thereof
08/16/2001WO2001059119A1 PROCESS FOR PRODUCING ISOELECTRICALLY HOMOGENIZED Fab' ANTIBODY AND FLUORESCENCE-LABELED ISOELECTRICALLY HOMOGENIZED Fab' ANTIBODY
08/16/2001WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5
08/16/2001WO2001059107A1 Novel scavenger receptors
08/16/2001WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses
08/16/2001WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/16/2001WO2001059089A2 Improved galactosylation of recombinant glycoproteins
08/16/2001WO2001059079A1 UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1
08/16/2001WO2001059075A1 Improved sialylation of glycoproteins
08/16/2001WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
08/16/2001WO2001058945A1 Dna encoding human vanilloid receptor vr3
08/16/2001WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof
08/16/2001WO2001058943A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same
08/16/2001WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES
08/16/2001WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
08/16/2001WO2001058921A2 Methods and compositions for generating angiostatin
08/16/2001WO2001058916A2 Antibodies to ccr5
08/16/2001WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10
08/16/2001WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease
08/16/2001WO2001058472A2 Botulinum toxin pharmaceutical compositions
08/16/2001WO2001058276A2 Use of acid-stable proteases in animal feed
08/16/2001WO2001058275A2 Use of acid-stable subtilisin proteases in animal feed
08/16/2001WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
08/16/2001WO2001012172B1 Treatment of metastatic disease
08/16/2001WO2001009190A3 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
08/16/2001WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same
08/16/2001WO2001005955A3 Animals comprising human hepatocellular tissue
08/16/2001WO2001002569A3 Human immune response molecules
08/16/2001WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase
08/16/2001WO2000036093A9 Intein-mediated cyclization of peptides
08/16/2001WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof
08/16/2001US20010014672 High molecular weight major outer membrane protein of moraxella
08/16/2001US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell
08/16/2001US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy
08/16/2001US20010014471 Antitumor agents
08/16/2001US20010014458 Human G-protein coupled receptor GPR6sb
08/16/2001US20010014333 Hybrid heterodimeric protein hormone and method of using same
08/16/2001US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen
08/16/2001US20010014327 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response
08/16/2001US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
08/16/2001EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
08/16/2001EP1123410A1 The enzyme-mediated synthesis of peptidomimetics
08/16/2001EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
08/16/2001EP1123397A2 G-protein coupled receptors
08/16/2001EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
08/16/2001EP1123393A1 Follistatin-related protein zfsta2
08/16/2001EP1123392A1 Prv-1 gene and the use thereof
08/16/2001EP1123391A2 Methods for improving the function of heterologous g protein-coupled receptors
08/16/2001EP1123315A1 Multiple domain glycoprotein hormones and methods of using
08/16/2001EP1123312A2 Human rna binding proteins
08/16/2001EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor
08/16/2001EP1123306A1 Inhibitors of platelet activation and recruitment
08/16/2001EP1123114A1 Virus-like particles for the induction of autoantibodies
08/16/2001EP1123004A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi
08/16/2001EP0839153B1 Process of preparation of peptides and n-carbamoyl protected peptides
08/16/2001EP0759944B1 Target cell binding chimaeric peptides
08/16/2001EP0749444B1 Hybrid human/animal factor viii
08/16/2001EP0698097B1 Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae
08/16/2001EP0576483B1 Biocidal proteins
08/16/2001CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001CA2400509A1 Regulated expression of plac in staphylococcus aureus
08/16/2001CA2400497A1 Methods and compositions for generating angiostatin
08/16/2001CA2400472A1 Il-17 like molecules and uses thereof
08/16/2001CA2400299A1 Dna encoding human vanilloid receptor vr3
08/16/2001CA2399945A1 Larynx carcinoma-associated protein larcap-1
08/16/2001CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses
08/16/2001CA2399860A1 Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1
08/16/2001CA2399593A1 Antibodies to ccr5
08/16/2001CA2399266A1 Improved galactosylation of recombinant glycoproteins
08/16/2001CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/16/2001CA2368681A1 Anti-angiogenic intestinal peptides, zdint5
08/15/2001CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
08/15/2001CN1308677A Human tumour-derived polyptde hormone phosphatonin
08/15/2001CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain
08/15/2001CN1308674A Multivalent T cell receptor complexes
08/15/2001CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis
08/15/2001CN1308087A Human testis specific protein gene coding protein
08/15/2001CN1069649C [B9 glutamic acid, B10 aspartic acid] human insulin
08/14/2001US6274789 Rice gene resistant to blast disease
08/14/2001US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla)
08/14/2001US6274710 Antibodies which specifically bind T Cell inducible factors (TIFs)
08/14/2001US6274702 Bone stimulating factor
08/14/2001US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues
08/14/2001US6274366 A dna expression construct transformed in yeast cells; treatment of angiogenesis and tissue remodeling
08/14/2001US6274365 A carrier compound containing an active recombinant furin enzyme; gene therapy; treatment of cancer
08/14/2001US6274362 RGS-containing molecules and uses thereof
08/14/2001US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies
08/14/2001US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides